24-001477 NEI-age-related eye disease study (areds) & age-related macular degeneration (AMD) metabolomics study 4TH continuation, per contract#q-02064. Send PO to
Ended Purchase Order Awarded Last action
- Contract number
- 75N98024P01214
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $484,401
Award facts
- Opportunity
-
- Metabolomics Evaluation of the Age-Related Eye Disease Study (AREDS) Special Notice · 75N98024P01214 · Posted Mar 14, 2024
- Contract value 100% obligated
- $484,401.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Eye Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Morrisville, NC, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Eye Institute awarded a $484,401.20 firm-fixed-price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, to conduct a non-targeted metabolomics evaluation of approximately 1,897 serum samples from participants aged 55 and older who were enrolled in the Age-Related Eye Disease Study 2 (AREDS2). This contract, which does not have a set-aside designation, is a 4th continuation of prior work and will have a 12-month period of performance. Metabolon, a leading provider of metabolomics solutions, will use its DiscoveryHD4 platform and expertise to analyze metabolic signatures associated with varying severity of age-related macular degeneration, with the goal of supporting the National Eye Institute's research initiatives in the areas of precision medicine and diagnostics.
Quick answers
Who was awarded contract 75N98024P01214?
75N98024P01214 was awarded to Metabolon, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on May 6, 2024.
How much is contract 75N98024P01214 worth?
The government has obligated $484,401 on 75N98024P01214.
Which agency awarded contract 75N98024P01214?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98024P01214, with funding from National Eye Institute (National Institutes of Health).
Was contract 75N98024P01214 competed?
The extent of competition for 75N98024P01214 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award